Non Invasive Assessment of Liver Glycogen Kinetics and ATP Synthesis in Type1 Diabetics
NCT00481598 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28
Last updated 2008-09-12
Summary
Patients with Type 1 diabetes (T1DM) suffer from impaired postprandial hepatic glycogen storage and breakdown, if they are under poor glycaemic control. Poor glycogen storage in the liver puts these patients at risk of fasting hypoglycaemia. Amelioration of glycaemic control could improve these abnormalities and thereby reduce the risk of hypoglycaemia in these patients. The "gold standard" technique for the assessment of hepatic glycogen metabolism in humans, 13 C magnetic resonance spectroscopy (13C-MRS), is expensive and limited to a few centers worldwide. Furthermore, treated type 1 diabetic patients exhibit skeletal muscle insulin resistance when treated insufficiently. This condition can also be reversed by improvement of glycaemic control. Recent studies link skeletal muscle insulin resistance to impaired mitochondrial function. Up to date, the impact of glycaemic control on skeletal muscle mitochondrial function has not yet been assessed.
Aim 1 of our project is to establish a new assessment method for glycogen metabolism. This new method is based on oral administration of 2H2O and acetaminophen.
Our second aim is to examine the impact of improvements of glycaemic control on skeletal muscle mitochondrial function in type 1 diabetic patients.
Our third aim is to assess the ATP-synthesis in T1DM.
We will conduct a prospective study on 14 patients with type 1 diabetes and 14 healthy controls.
On the respective study day, participants will be served three standardized meals, blood sugar will be controlled hourly and blood samples will be drawn at timed intervals to determine glucoregulatory hormones, metabolites and enrichments of \[6,6-2H2\]glucose.
During the night, four 13C-MRS-measurements will be performed in combination with \[6,6-2H2\]glucose infusion to assess glucose production, glycogen breakdown and gluconeogenesis.
In addition, patients will drink 3g/kg bodyweight 2H2O and acetaminophen will be administered. Thus the new 2H2O-acetaminophen method will be applied simultaneously with the "gold standard" method.
The following morning, mitochondrial function will be assessed in skeletal muscle from unidirectional flux through ATP synthase by 31P MRS.
TIDM patients will be studied twice. First, under conditions of insufficient glycaemic control and the second time after three months of intensified insulin treatment using CSII pumps aiming at optimized metabolic control. Healthy controls will be studied only once.
To assess muscular mitochondrial function in T1DM we will measure ATP synthesis in a calf muscle with magnetic resonance spectroscopy. First, we will conduct a basal measurement. Thereafter, we will start a hyperinsulinaemic euglycemic calmp to stimulate the ATP synthesis and measure again.
This study will provide information on rates of post absorptive glycogen breakdown, gluconeogenesis, and postprandial glycogen storage in the liver and on the skeletal muscle mitochondrial function under conditions of optimized glycaemic control for 3 months.
Finally, this study will demonstrate whether or not poorly controlled type 1 diabetic patients exhibit abnormalities in muscle mitochondrial function and to what extent those alterations can be reversed by optimized glycaemic control. We expect to validate the 2H2O-acetaminophen method, which will provide justification for a broad scale in clinical studies.
Conditions
- Type 1 Diabetes Mellitus
Interventions
- PROCEDURE
-
magnet resonance spectroscopy
magnet resonance spectroscopy
Sponsors & Collaborators
-
University of Coimbra
collaborator OTHER -
Landsteiner Institut
lead OTHER
Principal Investigators
-
Michael Roden, Professor Dr. · Landsteiner Institute
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-01-31
- Primary Completion
- 2008-07-31
- Completion
- 2008-09-30
Countries
- Austria
Study Locations
More Related Trials
-
Lipid and Glycogen Metabolism in Patients With Impaired Glucose Tolerance and Calcium Sensing Receptor Mutations
NCT02023489 ·Status: UNKNOWN ·Phase: NA
-
Prevalence of NAFLD and Advanced Fibrosis in Patients With Type 1 Diabetes
NCT04595474 ·Status: ACTIVE_NOT_RECRUITING
-
Cardiac Dysfunction in Adolescents With Type 1 Diabetes: Contribution of Daily-life Glucoregulation and Impact on Cardiorespiratory Exercise Capacity
NCT04052919 ·Status: COMPLETED ·Phase: NA
-
Assessment of the Neurovascular Microcirculatory Response in Diabetes Type 1 Patients
NCT02538120 ·Status: COMPLETED ·Phase: NA
-
The Influence of Acute Hyperglycaemia on Brain in T1D
NCT03188757 ·Status: COMPLETED ·Phase: NA
-
Involvement of Extrapancreatic Factors on Gastrointestinal-mediated Glucose Disposal
NCT02006459 ·Status: COMPLETED
-
Effect of Glucose on Ocular Blood Flow
NCT00350129 ·Status: COMPLETED
-
Prevalence, Incidence and Characteristics of NAFLD/NASH in Type 1 Diabetes Mellitus
NCT04664036 ·Status: UNKNOWN
-
Role of TMEM219 Marker in Type 1 Diabetes
NCT03794739 ·Status: UNKNOWN
-
Metabolic Profiling of Type 1 Diabetes Mellitus in Children and Adolescents
NCT03014908 ·Status: COMPLETED
-
Very-Low-Density-Lipoprotein-Triglyceride(VLDL-TG) Metabolism During Acute Hyperglycemia
NCT01178957 ·Status: COMPLETED
-
Glycemic Control, Brain Structure and Cognition in Youth With Type 1 Diabetes (T1DM)
NCT00879203 ·Status: COMPLETED
-
Vascular Inflammation in Adolescents With Type 1 Diabetes
NCT00933101 ·Status: COMPLETED
-
Retinal Function in Relation to Long Term Changes in the Glucose Level
NCT00973401 ·Status: UNKNOWN
-
The Effect of Type 1 Diabetes on Pan-Arterial Vascular Function and Insulin Sensitivity in Humans
NCT02490124 ·Status: COMPLETED
-
Effect of Metformin in Children With Type 1 Diabetes
NCT04879511 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study of Cellular Impairments Involved in Diabetic Complications
NCT00985101 ·Status: UNKNOWN
-
A Trial Investigating the Effect of Acute Hypoglycaemia on Cognitive Function and Brain Activation Patterns in Subjects With Type 1 Diabetes
NCT01789593 ·Status: COMPLETED ·Phase: PHASE1
-
System Accuracy of the Blood Glucose Monitor for Personal Use JT100
NCT05124834 ·Status: COMPLETED ·Phase: NA
-
Multicenter Assessment of the Pancreas in Type 1 Diabetes
NCT03585153 ·Status: ENROLLING_BY_INVITATION
-
Vascular Function in Adolescent, Diabetic Children
NCT00348179 ·Status: COMPLETED ·Phase: NA
-
Beta Cell Imaging in T1D Patients With a Different Glycemic Control
NCT03785275 ·Status: TERMINATED
-
Glucose-stimulated Pancreatic Islet and Intestinal Blood Flow in Healthy Subjects and in Type 1 Diabetes
NCT02547337 ·Status: COMPLETED
-
Microvascular Changes in OCT-angiography in Type 1 Diabetes Mellitus at the Onset of the Disease and After Optimization of Glycemic Control.
NCT04888598 ·Status: UNKNOWN
-
The Electroretinogram in Healthy and Glucose Intolerant Young Men
NCT01140932 ·Status: COMPLETED ·Phase: NA